Trials / Completed
CompletedNCT00179049
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
Detailed description
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease (GVHD) by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Their understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.
Conditions
Timeline
- Start date
- 2003-04-01
- Completion
- 2008-04-01
- First posted
- 2005-09-15
- Last updated
- 2008-12-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00179049. Inclusion in this directory is not an endorsement.